News from cardiofocus, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 19, 2022, 10:30 ET CardioFocus Announces Pulsed Field Ablation Milestones

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatments for atrial fibrillation (Afib), today announced several...

Jul 19, 2021, 09:00 ET CardioFocus to Exhibit and Present Data Supporting HeartLight X3 System at Heart Rhythm 2021

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced its...

Jun 29, 2021, 09:00 ET CardioFocus Appoints Stephan Ogilvie as Chief Financial Officer

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced the appointment ...

Jun 23, 2021, 09:00 ET CardioFocus Receives Regulatory Approval to Market HeartLight X3 System in Japan

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced that the...

Jun 02, 2021, 08:00 ET CardioFocus Announces Agreement with China Grand Pharmaceutical to Bring HeartLight X3 System to China

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatments for atrial fibrillation (AFib), announced today that it has...

Mar 16, 2021, 09:00 ET CardioFocus Invited To Participate At The Oppenheimer 31st Annual Healthcare Conference

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced that Chief...

Feb 25, 2021, 09:00 ET CardioFocus Announces The Publication Of HeartLight X3 Pivotal Study Data

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), announced today that results...

Feb 02, 2021, 09:00 ET CardioFocus Announces Expanded Partnership With Japan Lifeline

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatments for atrial fibrillation (AFib), announced today that it has...

Jan 12, 2021, 09:00 ET CardioFocus Invited To Participate In 23rd Annual ICR Conference And Needham Virtual Growth Conference

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced that Chief...

Jan 11, 2021, 09:00 ET CardioFocus® Announces Expanded Distribution Partnership With MicroPort™ CRM To Include Spain And Portugal

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), announced today that it has...

Jan 11, 2021, 09:00 ET CardioFocus® annonce un partenariat de distribution étendu avec MicroPort™ CRM en vue d'inclure l'Espagne et le Portugal

CardioFocus, Inc., une société de dispositifs médicaux dédiée à l'avancement du traitement par ablation de la fibrillation auriculaire (FA), a...

Jan 11, 2021, 09:00 ET A CardioFocus® anuncia uma parceria alargada de distribuição com a MicroPort™ CRM para incluir Espanha e Portugal

A CardioFocus, Inc., uma empresa de dispositivos médicos dedicada ao avanço do tratamento de ablação para fibrilação atrial (AFib), anunciou hoje que ...

Jan 11, 2021, 09:00 ET CardioFocus® amplía la asociación de distribución con MicroPort™ CRM para incluir a España y Portugal

CardioFocus, Inc., una empresa de dispositivos médicos dedicada a propiciar el tratamiento de la ablación de la fibrilación auricular (AFib), ha...

Dec 15, 2020, 09:00 ET CardioFocus Announces 10,000 Patients Treated Worldwide

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), announced today that more than...

Jun 16, 2020, 09:00 ET CardioFocus® Announces Initial Commercial Procedures Following US FDA Approval of HeartLight® X3 System for the Treatment of Atrial Fibrillation

CardioFocus, Inc. today announced that the first U.S. patients have been treated commercially with the recently-approved HeartLight® X3 Endoscopic...

May 12, 2020, 09:00 ET CardioFocus Announces US FDA Approval of HeartLight® X3 System for the Treatment of Atrial Fibrillation

CardioFocus, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the next-generation HeartLight® X3 Endoscopic...

Feb 04, 2020, 09:00 ET CardioFocus Announces U.S. FDA PMA Supplement Submission For The Breakthrough HeartLight X3 Endoscopic Ablation System

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced that the...

Jan 22, 2020, 09:00 ET CardioFocus® Names Burke T. Barrett As Chief Executive Officer

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), announced today that the...

Oct 29, 2019, 09:53 ET CardioFocus® traite les premiers patients à l'aide du système d'ablation endocospique HeartLight® en France

CardioFocus, Inc., une société de technologie médicale dont la mission est de promouvoir le traitement par ablation de la fibrillation auriculaire...

Oct 29, 2019, 08:30 ET CardioFocus® Treats First Patients With HeartLight® Endoscopic Ablation System In France

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), announced today that the first...

Jun 18, 2019, 10:00 ET CardioFocus Launches 100th HeartLight® Center Worldwide

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), announced today that the...

May 28, 2019, 09:00 ET CardioFocus Secures $55 Million In Financing

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced the completion...

May 10, 2019, 12:00 ET CardioFocus Announces Impressive Results From Pivotal Confirmatory Study With The Breakthrough HeartLight® X3 System

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced the...

Mar 25, 2019, 08:30 ET CardioFocus Announces European CE Mark Approval Of Breakthrough HeartLight® X3 System For The Treatment Of Atrial Fibrillation

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced the European CE ...

Mar 25, 2019, 08:30 ET CardioFocus gibt Zulassung für HeartLight® X3-System zur Behandlung von Vorhofflimmern bekannt.

CardioFocus, Inc., ein Medizintechnik-Unternehmen, das sich der Ablationsbehandlung von Vorhofflimmern verschrieben hat, gab heute die europäische...